Lucid Diagnostics, Inc. (LUCD)
0.4077
+0.01
(+2.18%)
USD |
NASDAQ |
Nov 18, 16:00
0.399
-0.01
(-2.13%)
After-Hours: 20:00
Lucid Diagnostics Gross Profit Margin (Quarterly) : -35.41% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -35.41% |
| June 30, 2026 | -13.23% |
| March 31, 2026 | -47.05% |
| December 31, 2025 | -37.57% |
| September 30, 2025 | -58.30% |
| June 30, 2025 | -53.48% |
| March 31, 2025 | -114.0% |
| December 31, 2024 | -97.74% |
| September 30, 2024 | -62.03% |
| June 30, 2024 | -88.83% |
| March 31, 2024 | -115.5% |
| Date | Value |
|---|---|
| December 31, 2023 | -100.6% |
| September 30, 2023 | -188.5% |
| June 30, 2023 | -1.27K% |
| March 31, 2023 | -337.2% |
| December 31, 2022 | -1.89K% |
| September 30, 2022 | -2.82K% |
| June 30, 2022 | |
| March 31, 2022 | -107.9% |
| December 31, 2021 | -47.10% |
| September 30, 2021 | 27.65% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| PAVmed, Inc. | -331.7% |
| Stereotaxis, Inc. | 44.32% |
| Glaukos Corp. | 85.23% |
| CVRx, Inc. | 85.15% |
| Hyperfine, Inc. | 56.74% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -421.1% |
| Return on Assets | -124.8% |
| Return on Invested Capital | -136.4% |
| Profit Margin (Quarterly) | -555.0% |
| Operating Margin (Quarterly) | -1.02K% |
| Return on Net Operating Assets | -883.9% |